Abstract
Macrophages are critical mediators of tissue homeostasis, with tumours distorting this proclivity to stimulate proliferation, angiogenesis and metastasis. This had led to an interest in targeting macrophages in cancer, and preclinical studies have demonstrated efficacy across therapeutic modalities and tumour types. Much of the observed efficacy can be traced to the suppressive capacity of macrophages, driven by microenvironmental cues such as hypoxia and fibrosis. As a result, tumour macrophages display an ability to suppress T cell recruitment and function as well as to regulate other aspects of tumour immunity. With the increasing impact of cancer immunotherapy, macrophage targeting is now being evaluated in this context. Here, we discuss the results of clinical trials and the future of combinatorial immunotherapy.
Keywords
ImmunotherapyImmune systemCancer immunotherapyMacrophageImmunityTumor microenvironmentAngiogenesisImmunologyCancer researchContext (archaeology)BiologyMetastasisCancerMedicineIn vitro
MeSH Terms
AnimalsAntigen PresentationHumansImmunotherapyLymphocytesMacrophagesNeoplasmsPhagocytosis
Affiliated Institutions
Related Publications
Macrophages as tools and targets in cancer therapy
Tumour-associated macrophages are an essential component of the tumour microenvironment and have a role in the orchestration of angiogenesis, extracellular matrix remodelling, c...
Targeting macrophages: therapeutic approaches in cancer
Infiltration of macrophages in solid tumours is associated with poor prognosis and correlates with chemotherapy resistance in most cancers. In mouse models of cancer, macrophage...
Diversity, Mechanisms, and Significance of Macrophage Plasticity
Macrophages are a diverse set of cells present in all body compartments. This diversity is imprinted by their ontogenetic origin (embryonal versus adult bone marrow–derived cell...
The macrophage: Past, present and future
As we approach the centenary of Elie Metchnikoff's Nobel Prize (1908), it is opportune to reflect upon the history of macrophage immunobiology, take stock of current knowledge a...
The immunosuppressive tumour network: myeloid‐derived suppressor cells, regulatory T cells and natural killer T cells
Summary Myeloid‐derived suppressor cells ( MDSC ) and regulatory T (Treg) cells are major components of the immune suppressive tumour microenvironment ( TME ). Both cell types e...
Publication Info
- Year
- 2019
- Type
- review
- Volume
- 19
- Issue
- 6
- Pages
- 369-382
- Citations
- 2304
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
2304
OpenAlex
63
Influential
Cite This
David G. DeNardo,
Brian Ruffell
(2019).
Macrophages as regulators of tumour immunity and immunotherapy.
Nature reviews. Immunology
, 19
(6)
, 369-382.
https://doi.org/10.1038/s41577-019-0127-6
Identifiers
- DOI
- 10.1038/s41577-019-0127-6
- PMID
- 30718830
- PMCID
- PMC7339861